Strategic Acquisition VitalFlo was acquired by Doktorconnect in April 2025, signaling potential integration opportunities, cross-sell of respiratory health solutions, and expanded distribution through a larger preventative care platform.

Respiratory Monitoring Focus The company specializes in spirometry-based lung health assessment for primary care and at-home use, presenting opportunities to upsell to practices expanding remote monitoring, COPD and asthma management programs, and value-based care initiatives.

Small Team, High Agility With a lean headcount and a funded footprint, VitalFlo offers a nimble collaboration profile for pilots, early adopters, and scalable integrations within larger health tech ecosystems.

Revenue and Partnerships Existing revenue from reimbursement codes and prior partnerships with Vitalograph, Ambee, and Allergy & Asthma Network suggest a proven channel strategy; leverage these relationships to expand payer- and device-integrated solutions.

Growth Signals Past expansions into home-based virtual care and ongoing cloud-based data platforms indicate readiness for enterprise deployments, data analytics partnerships, and regional expansion through Doktorconnect’s preventative care network.